Central South Univ. FAK compound 7d

Central South Univ. FAK compound 7d: sourced facts only. name: "Together, 7d is a novel FAK inhibitor to inhibit the essential nonkinase scaffolding function of FAK via binding FAT domain and may be worth studying further for intervention of TNBC." [PMID:35569251]; target: "Together, 7d is a novel FAK inhibitor to inhibit the essential nonkinase scaffolding function of FAK via binding FAT domain and may be worth studying further for intervention of TNBC." [PMID:35569251]; developer: "Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, PR China; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, PR China." [PMID:35569251]; stage: "The most active compound 7d could potently inhibit the proliferation, invasion and migration of TNBC cells in vitro." [PMID:35569251]